Minimally Invasive Endoscopic Treatment of Zenker's Diverticulum Comparing LigaSureTM vs SB-Knife.
1 other identifier
interventional
80
1 country
1
Brief Summary
The main purpose of this trial is to evaluate two devices used in the treatment of Zenker Diverticulum using flexible endoscopy (LigaSure and SB-knife). Analyze the technical success, clinical success, relapses, complications, and the mean procedure time with each device prospectively in order to transfer objective and uniform results to routine clinical practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 24, 2020
CompletedFirst Posted
Study publicly available on registry
December 9, 2020
CompletedStudy Start
First participant enrolled
June 28, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedFebruary 23, 2024
February 1, 2024
3 years
November 24, 2020
February 22, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Evaluate the technical success of endoscopic diverticulotomy with SB-Knife and LigaSure
Technical success: achieving septotomy of the mucosa and transverse muscle fibers of the diverticulum septum.
At the moment of the procedure
Evaluate clinical success of endoscopic diverticulotomy with SB-Knife and LigaSure
Clinical success: disappearance of symptoms or their improvement one month after treatment, evaluated using the Eating-Assessment Tool-10 (\>=3 pathological) and Dakkak and Bennett scales (0: asymthomatic; 4 aphagia)
One month after the procedure
Secondary Outcomes (3)
Analyze the mean procedure time with each of the two endoscopic techniques
At the end of the recruitment
Analyze immediate and delayed complications with SB-Knife and LigaSure
one month after the procedure
Determine the recurrence rates and the mean time to recurrence for each of the techniques
at least three months after the procedure
Study Arms (2)
Vessel sealing device
ACTIVE COMPARATOREndoscopic diverticulectomy is performed with the LigaSure (TM) device
Dissecting Knife device
ACTIVE COMPARATOREndoscopic diverticulectomy is performed with the SB-Knife(TM) device
Interventions
Eligibility Criteria
You may qualify if:
- Patients with endoscopically confirmed Zenker's diverticulum and presenting symptoms related to it.
- Those who complete the symptom and quality of life questionnaires.
- They must sign informed consent.
You may not qualify if:
- Previous treatment of Zenker's Diverticulum
- Those for whom Zenker's diverticulum is ruled out at endoscopy.
- Chewing disorders and/or dysphagia secondary to neurological pathology and Oesophageal motility disorders
- Those who do not want to participate in the study and/or who do not sign the informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mª Henar Núñez Rodriguez,
Valladolid, 47001, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mª Henar Núñez-Rodriguez, MD PhD
Gastroenterology Department, Hospital Rio Hortega
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 24, 2020
First Posted
December 9, 2020
Study Start
June 28, 2021
Primary Completion
June 30, 2024
Study Completion (Estimated)
December 31, 2026
Last Updated
February 23, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share